規制動向
2026年9月16日•3分で読めます
FDA Approves ANDA203048 for Clindamycin Phosphate Injection by Rising
The FDA granted approval for Rising’s clindamycin phosphate injection products (6, 12, and 18 mg/mL) under application ANDA203048.
規制動向
2026年9月15日•3分で読めます
FDA Grants Labeling Approval for Olmesartan Medoxomil Tablets (ANDA 078276)
FDA has approved labeling for oral Olmesartan Medoxomil tablets (5 mg, 20 mg, 40 mg) under ANDA 078276 submitted by Rising; the products are listed as discontinued.